Stay updated on Nivolumab Combo in Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in Head & Neck Cancer Clinical Trial page.

Latest updates to the Nivolumab Combo in Head & Neck Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a new build of the page. There are no visible changes to study details or user-facing content reflected in this update.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe page reflects an update to the site’s revision version from v3.5.2 to v3.5.3, indicating an underlying platform/admin release rather than content changes to the trial record.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision: v3.5.2 was added; Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision notes show the addition of v3.5.0 and removal of v3.4.3.SummaryDifference0.1%

- Check80 days agoChange DetectedThe revision tag on the page was updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check94 days agoChange DetectedThe sponsor and affiliated institution names were updated to the official designation: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University. The page now lists Thomas Jefferson University (Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University) and removes the alternate aliases to standardize naming.SummaryDifference0.3%

Stay in the know with updates to Nivolumab Combo in Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Head & Neck Cancer Clinical Trial page.